RecruitingPhase 3NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Sponsor: Bristol-Myers Squibb
Ozark, MO · +41 more sites
5 recruiting studies have a site in or near Ozark, MO, Missouri.
Showing 5 of 5 studies
Sponsor: Bristol-Myers Squibb
Ozark, MO · +41 more sites
Sponsor: Pfizer
Ozark, MO · Springfield, MO · +167 more sites
Sponsor: Pfizer
Ozark, MO · Springfield, MO · +113 more sites
Sponsor: AbbVie
Ozark, MO · +124 more sites
Sponsor: ModernaTX, Inc.
Ozark, MO · St Louis, MO · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.